Aspirin for premature birth

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Feb 2025: Trial registered, NCT06826859
  2. 26 Jun 2025: Trial started, NCT06826859

The trials

NCT06826859: Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)

State
Under way
Phase
Phase 1 and Phase 2
People
400 planned
Started
26 Jun 2025
Primary completion
1 Jul 2029
Arms
Split dose aspirin
Results
None posted
  1. 14 Feb 2025: Trial registered
  2. 26 Jun 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Also known as Asa, Aspirin 100mg, Aspirin 100mg for 1-month (immediately after PCI), Aspirin 100mg for 6-month (6-month post PCI), Clopidogrel/acetylsalicylic acid component aspirin, CoPRIME aspirin alone, Duocover component aspirin, Duoplavin component aspirin, Durlaza, Measurin, Yosprala component aspirin.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.